Excessive Pricing Causes Poor Access to Biologics.
Excessive Pricing Causes Poor Access to Biologics.
J Rheumatol. 2018 Jun;45(6):876
Authors: Boers M
PMID: 29858458 [PubMed - in process]
Source: J Rheumatol - Category: Rheumatology Authors: Boers M Tags: J Rheumatol Source Type: research
More News: Rheumatology